ロード中...
Trastuzumab for the Treatment of Salivary Duct Carcinoma
OBJECTIVES. Salivary duct carcinoma (SDC) is a rare and aggressive malignancy with high mortality and poor response to treatment. A significant fraction of SDCs are HER2 positive. This retrospective review examines HER2 testing in SDC and the outcome of trastuzumab-based therapy in adjuvant and pall...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607526/ https://ncbi.nlm.nih.gov/pubmed/23429737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0369 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|